| COMPOSITION | |
|---|---|
| CLOTRIMAZOLE | 1% |
| BECLOMETHASONE | – |
CLOTRIMAZOLE & BECLOMETHASONE
KOZYVIB B
| SPECIFICATION | |
|---|---|
| FORM | TUBE |
| PACKING | 15 GM |
| PACKING TYPE | CREAM |
| MRP | 56 |
SIMILAR PRODUCTS
DESCRIPTION
An imidazole derivative with a broad spectrum of antimycotic activity. It inhibits biosynthesis of the sterol ergostol, an important component of fungal cell membranes. Its action leads to increased membrane permeability and apparent disruption of enzyme systems bound to the membrane. [PubChem]
SIDE EFFECTS
Symptoms of overdose include erythema, stinging, blistering, peeling, edema, pruritus, urticaria, burning, and general irritation of the skin, and cramps.
INDICATION
For the local treatment of oropharyngeal candidiasis and vaginal yeast infections, also used in fungal infections of the skin such as ringworm, athlete’s foot, and jock itch.